{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:11:35Z","timestamp":1791882695029,"version":"4.3.4"},"reference-count":95,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Oncol Pract"],"published-print":{"date-parts":[[2026,9]]},"abstract":"\n \n \n ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the<\/jats:italic>\n \n ASCO Guidelines Methodology Manual<\/jats:italic>\n <\/jats:ext-link>\n . ASCO Guidelines follow the<\/jats:italic>\n \n ASCO Conflict of Interest Policy for Clinical Practice Guidelines<\/jats:italic>\n <\/jats:ext-link>\n .\n <\/jats:p>\n \n \n Clinical Practice Guidelines and other guidance (\u201cGuidance\u201d) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by clinicians and should be used in conjunction with independent professional judgment. Guidance may not be applicable to all patients, interventions, diseases, or stages of diseases. Guidance is based on review and analysis of relevant literature and is not intended as a statement of the standard of care. ASCO does not endorse third-party drugs, devices, services, or therapies and assumes no responsibility for any harm arising from or related to the use of this information. See complete disclaimer in\n Appendix 1<\/jats:xref>\n and\n 2<\/jats:xref>\n (online only) for more\n <\/jats:italic>\n .\n <\/jats:p>\n <\/jats:sec>\n \n PURPOSE<\/jats:title>\n To provide guidance on the use of circulating tumor DNA (ctDNA) testing in patients with solid tumors or lymphoma.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n A systematic review by a multidisciplinary panel with patient representation was conducted. The PubMed database was searched from January 2017 to February 2025. Guideline recommendations were based on consideration of the identified evidence.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n Fifty-four meta-analyses and 22 study reports were identified, including reports of seven randomized trials.<\/jats:p>\n <\/jats:sec>\n \n RECOMMENDATIONS<\/jats:title>\n ctDNA testing for tumor genetic alterations may be used in situations where: tumor tissue testing is challenging, not feasible, or tumor biopsy represents unacceptable risks to the patient; tumor tissue testing results may not be available within a clinically actionable time frame to determine appropriate management options; or a drug's regulatory approved indication allows for or requires ctDNA testing. If ctDNA testing results are negative, inconclusive, or inconsistent with the clinical scenario, tissue-based confirmation should be sought. Other than testing for genetic alterations, ctDNA testing may be offered if a specific, evidence-based action can be taken with the results or there is conflict or ambiguity with standard-of-care assessment that may be resolved by ctDNA testing. Fractional, percentage, or concentration-based measures of ctDNA or total cell-free DNA concentration are not recommended as a surrogate measure of disease. The panel recognizes this is a rapidly evolving field and guidelines are anticipated to change, bringing in tumor-type specific recommendations and incorporating more data on molecular residual disease settings.<\/jats:p>\n \n Additional information is available at\n www.asco.org\/molecular-testing-and-biomarkers-guidelines<\/jats:ext-link>\n .\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1200\/op-26-00311","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:59:10Z","timestamp":1781812750000},"page":"1468-1489","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":12,"title":["Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline"],"prefix":"10.1200","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-7604","authenticated-orcid":true,"given":"Christina M.","family":"Lockwood","sequence":"first","affiliation":[{"name":"University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4585-9906","authenticated-orcid":true,"given":"Hans J.","family":"Messersmith","sequence":"additional","affiliation":[{"name":"American Society of Clinical Oncology, Alexandria, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-2439","authenticated-orcid":true,"given":"Annette S.","family":"Kim","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-0819","authenticated-orcid":true,"given":"Padma Sheila","family":"Rajagopal","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3518-0411","authenticated-orcid":true,"given":"Umang","family":"Swami","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5532-6524","authenticated-orcid":true,"given":"Rena","family":"Xian","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5203-5932","authenticated-orcid":true,"given":"Dara","family":"Aisner","sequence":"additional","affiliation":[{"name":"University of Colorado, Denver, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-6554","authenticated-orcid":true,"given":"Maria E.","family":"Arcila","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Kurttila","sequence":"additional","affiliation":[{"name":"Citrus Hills, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-6361","authenticated-orcid":true,"given":"Christine M.","family":"Lovly","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0865-3394","authenticated-orcid":true,"given":"Jason D.","family":"Merker","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5090-4801","authenticated-orcid":true,"given":"Kanika G.","family":"Nair","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4830-8365","authenticated-orcid":true,"given":"Atara Isaiah","family":"Ntekim","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Ibadan, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie Anne","family":"Sheen","sequence":"additional","affiliation":[{"name":"Ochsner Health System, New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2713-233X","authenticated-orcid":true,"given":"Apostolia Maria","family":"Tsimberidou","sequence":"additional","affiliation":[{"name":"University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8937-0873","authenticated-orcid":true,"given":"Nicholas C.","family":"Turner","sequence":"additional","affiliation":[{"name":"The Royal Marsden NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6948-0143","authenticated-orcid":true,"given":"Stacy W.","family":"Gray","sequence":"additional","affiliation":[{"name":"City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.8671"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0901-SA"},{"key":"e_1_3_8_4_2","volume-title":"GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations","author":"Sch\u00fcnemann H","year":"2013","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, et al: GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. The GRADE Working Group, 2013"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"e_1_3_8_6_2","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5","author":"Higgins JPT","year":"2024","unstructured":"Higgins JPT, Thomas J, Chandler J, et al: Cochrane Handbook for Systematic Reviews of Interventions Version 6.5, Cochrane, 2024"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005854"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01816-4"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2019.1626723"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-024-00725-x"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-022-04144-4"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0093"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doab046"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.26921"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032939"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202199"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02017-9"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103187"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01222"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12366-7"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231177008"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2024.01.003"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00924-y"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S123954"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032928"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021196"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.02.027"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53271-6"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00290"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.11.023"},{"key":"e_1_3_8_31_2","first-page":"8019652","article-title":"Prognostic value of circulating tumour DNA in Asian patients with hepatocellular carcinoma: A systematic review and meta-analysis","volume":"2022","author":"Liu H","year":"2022","unstructured":"Liu H, Yang H, Chen X: Prognostic value of circulating tumour DNA in Asian patients with hepatocellular carcinoma: A systematic review and meta-analysis. Evid Based Complement Alternat Med 2022:8019652, 2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/15330338211043784"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S195342"},{"key":"e_1_3_8_34_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20291"},{"key":"e_1_3_8_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13842"},{"key":"e_1_3_8_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1015161"},{"key":"e_1_3_8_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30780-4"},{"key":"e_1_3_8_38_2","first-page":"e1544","article-title":"EGFR-plasma mutations in prognosis for non-small cell lung cancer treated with EGFR TKIs: A meta-analysis","volume":"5","author":"Phan TT","year":"2022","unstructured":"Phan TT, Tran VT, Tran BT, et al: EGFR-plasma mutations in prognosis for non-small cell lung cancer treated with EGFR TKIs: A meta-analysis. Cancer Rep (Hoboken) 5:e1544, 2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"e_1_3_8_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2022.2064551"},{"key":"e_1_3_8_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010197"},{"key":"e_1_3_8_41_2","doi-asserted-by":"publisher","DOI":"10.5301\/ijbm.5000295"},{"key":"e_1_3_8_42_2","doi-asserted-by":"publisher","unstructured":"Tolmeijer SH Boerrigter E Schalken JA et al: A systematic review and meta-analysis on the predictive value of cell-free DNA-based androgen receptor copy number gain in patients with castration-resistant prostate cancer. JCO Precis Oncol 10.1200\/PO.20.00084","DOI":"10.1200\/PO.20.00084"},{"key":"e_1_3_8_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0740-y"},{"key":"e_1_3_8_44_2","doi-asserted-by":"publisher","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-3.16592"},{"key":"e_1_3_8_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.671874"},{"key":"e_1_3_8_46_2","doi-asserted-by":"publisher","DOI":"10.1177\/2472630320939565"},{"key":"e_1_3_8_47_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25314"},{"key":"e_1_3_8_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1989"},{"key":"e_1_3_8_49_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248775"},{"key":"e_1_3_8_50_2","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0671"},{"key":"e_1_3_8_51_2","first-page":"167","article-title":"Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis","volume":"7","author":"Yi Z","year":"2017","unstructured":"Yi Z, Liu B, Guan X, et al: Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis. Mol Clin Oncol 7:167-172, 2017","journal-title":"Mol Clin Oncol"},{"key":"e_1_3_8_52_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2023.2167555"},{"key":"e_1_3_8_53_2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6233904"},{"key":"e_1_3_8_54_2","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2020-0334"},{"key":"e_1_3_8_55_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.795933"},{"key":"e_1_3_8_56_2","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S161382"},{"key":"e_1_3_8_57_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6660571"},{"key":"e_1_3_8_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021965"},{"key":"e_1_3_8_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3276"},{"key":"e_1_3_8_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018581"},{"key":"e_1_3_8_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113310"},{"key":"e_1_3_8_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.11.005"},{"key":"e_1_3_8_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04030-w"},{"key":"e_1_3_8_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03579-w"},{"key":"e_1_3_8_65_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200075"},{"key":"e_1_3_8_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.12.011"},{"key":"e_1_3_8_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.02.012"},{"key":"e_1_3_8_68_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2511885"},{"key":"e_1_3_8_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5245"},{"key":"e_1_3_8_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.10.002"},{"key":"e_1_3_8_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2502929"},{"key":"e_1_3_8_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00555-1"},{"key":"e_1_3_8_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.1779"},{"key":"e_1_3_8_74_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.25332"},{"key":"e_1_3_8_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02115-4"},{"key":"e_1_3_8_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03254-6"},{"key":"e_1_3_8_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05828-w"},{"key":"e_1_3_8_78_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab030"},{"key":"e_1_3_8_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezaa018"},{"key":"e_1_3_8_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2021.06.008"},{"key":"e_1_3_8_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.993"},{"key":"e_1_3_8_82_2","doi-asserted-by":"publisher","unstructured":"Lak NSM van Zogchel LMJ Zappeij-Kannegieter L et al: Cell-free DNA as a diagnostic and prognostic biomarker in pediatric rhabdomyosarcoma. JCO Precis Oncol 10.1200\/PO.22.00113","DOI":"10.1200\/PO.22.00113"},{"key":"e_1_3_8_83_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb5427"},{"key":"e_1_3_8_84_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0623"},{"key":"e_1_3_8_85_2","doi-asserted-by":"publisher","DOI":"10.1159\/000497037"},{"key":"e_1_3_8_86_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8909224"},{"key":"e_1_3_8_87_2","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920915305"},{"key":"e_1_3_8_88_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-3335"},{"key":"e_1_3_8_89_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00638"},{"key":"e_1_3_8_90_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003981"},{"key":"e_1_3_8_91_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.2311"},{"key":"e_1_3_8_92_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02608"},{"key":"e_1_3_8_93_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00662"},{"key":"e_1_3_8_94_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02225"},{"key":"e_1_3_8_95_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02767"},{"key":"e_1_3_8_96_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02960"}],"container-title":["JCO Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/OP-26-00311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:59:56Z","timestamp":1789423196000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/OP-26-00311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1200\/OP-26-00311"],"URL":"https:\/\/doi.org\/10.1200\/op-26-00311","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1200\/GDL.26.0618","asserted-by":"subject"}]},"ISSN":["2688-1527","2688-1535"],"issn-type":[{"value":"2688-1527","type":"print"},{"value":"2688-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}